• Thu, July 7, 2022

Graig Suvannavejh Initiated (BTAI) at Strong Buy and Held Target at $19 on, Jul 7th, 2022

Graig Suvannavejh of Mizuho, Initiated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $19 on, Jul 7th, 2022.

Graig has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 0 agree with Graig's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Graig


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $110 on, Monday, May 23rd, 2022
  • Corinne Jenkins of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $10 on, Monday, May 9th, 2022

Like: 👍